Trial Profile
A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2018
Price :
$35
*
At a glance
- Drugs Potassium-dobesilate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors AmDerma Pharmaceuticals
- 25 Sep 2018 Status changed from recruiting to completed.
- 10 Jul 2017 New trial record